In HCC context, cross-presentation of antigens appears between pericancerous macrophages and CD103+ CTLs, causing the CD103+ CTLs accumulation in the pericancerous area, then promoting tumor progression as well as immunotherapy resistance [109]. The gene discussed is ITGAE; the disease is hepatocellular carcinoma.